Rise in Adoption of Advanced Diagnostic Techniques Step-Up the Automated Immunoassay Analyzers Market

Immunoassay is a biochemical test that measures the concentration of analytes in blood samples. The test generally relies on the capability of binding an antibody to a specific structure of molecules in analytes. It can be performed in laboratories or on-site with the help of an instrument called immunoassay analyzer. Immunoassay analyzers are employed to measure the presence or concentration of proteins in analyte samples using the antigen-antibody binding properties. The instrument identifies and quantifies the presence of specific substances in the sample by using antibodies as reagent. It determines the binding of that specific antibody to the target analytes. Automated immunoassay analyzers are used to test multiple samples simultaneously, with minimal human assistance. The samples can be processed individually or in batches, depending upon the size of samples.

Obtain Report Details @ http://www.transparencymarketresearch.com/automated-immunoassay-analyzers-market.html

Rise in adoption of advanced diagnostic techniques and high prevalence of chronic and infectious diseases across the globe are the major factors driving the automated immunoassay analyzers market. However, high cost of instruments and poor reimbursement policies for manufacturers in developing countries are expected to restrain the automated immunoassay analyzers market during the forecast period.

The global automated immunoassay analyzers market can be segmented based on application and end-user. In terms of application, the global automated immunoassay analyzers market can be segmented into cardiology disease testing, oncology marker testing, infectious disease testing, autoimmune diseases testing, and therapeutic drug monitoring. Oncology markers testing and cardiology testing segments dominated the global automated immunoassay analyzers market in 2016, led by the increase in investments by manufacturers in the healthcare sector. High prevalence of oncology and rise in adoption of automated clinical diagnostic tools are the key factors expected to propel the oncology markers testing segment during the forecast period. The therapeutic drug monitoring segment is anticipated to expand at a fast-paced CAGR during the forecast period, owing to the increase in demand for quicker and precise measurements of test samples

Based on end-user, the global automated immunoassay analyzers market can be bifurcated into clinical laboratories and hospitals. The hospitals segment held significant share of the automated immunoassay analyzers market in 2016, as these instruments are more popular in developed countries due to their compact nature. Less time required for the measurement of analyte concentration by automated analyzers and improved workflow due to easy & comprehensive technology are the prominent factors estimated to boost the hospitals segment during the forecast period.

Geographically, the global automated immunoassay analyzers market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for key share of the market in 2016, led by the rise in demand for technologically advanced clinical diagnostic instruments in the U.S. and presence of large patient pool suffering from chronic diseases such as cancer and tuberculosis. Increase in prevalence of infectious diseases in emerging countries such as India and China and ongoing research activities in the microbiological sector are boosting the automated immunoassay analyzers market in Asia Pacific. However, North America is likely to retain its dominance in the market during the forecast period, which is attributed to the high accuracy & precision rate of the automated immunoassay instruments, and its capability to perform multiple immunoassays on different samples simultaneously.

Fill the Form to Gain Deeper Insights on this Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26129

Abbott, bioMérieux India Private Limited, Beckman Coulter, Inc., The Binding Site Group Ltd., Bio-Rad Laboratories, Inc., Diamedix, Inc, DiaSorin S.p.A., Olympus America Inc., F. Hoffmann-La Roche Ltd, Siemens Medical Solutions Diagnostics, Trinity Biotech, and DRG International, Inc. are the prominent players operating in the global automated immunoassay analyzers market. Invention of new methods to introduce samples in analyzers is the new trend followed by these key players.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.